Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Small interfering RNA (siRNA), chemically modified to treat inflammatory (particularly intestinal) inflammatory diseases, by silencing TNF-alpha expression. These siRNA show high inhibitory activity and produc lower non-specific immune response More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 220 pages - $1,495
Jan 2008 - 148 pages - $1,740
Feb 2011 - 67 pages - $500
Dec 2010 - 54 pages - $2,000
Sep 2011 - 94 pages - $3,500
Sep 2011 - 134 pages - $500
Aug 2011 - 81 pages - $3,835
Jul 2006 - 240 pages - $3,500
May 2011 - 35 pages - $500
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us